HEADER ANTIVIRAL PROTEIN 03-AUG-22 8DXU TITLE FAB ARMS OF ANTIBODIES GAR03 AND 10G4 BOUND TO THE RECEPTOR BINDING TITLE 2 DOMAIN OF SARS-COV-2 IN A 1:1:1 COMPLEX. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: R; COMPND 4 FRAGMENT: RECEPTOR BINDING DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: SARS-COV-2 RECEPTOR BINDING DOMAIN RESIDUES 333-528, COMPND 7 WITH C-TERMINAL 6HIS TAG.; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HEAVY CHAIN OF FAB ARM OF ANTIBODY 10G4; COMPND 10 CHAIN: H; COMPND 11 ENGINEERED: YES; COMPND 12 OTHER_DETAILS: HEAVY CHAIN OF FAB ARM OF ANTIBODY 10G4; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: LIGHT CHAIN OF FAB ARM OF ANTIBODY 10G4; COMPND 15 CHAIN: L; COMPND 16 ENGINEERED: YES; COMPND 17 OTHER_DETAILS: LIGHT CHAIN OF FAB ARM OF ANTIBODY 10G4; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: HEAVY CHAIN OF FAB ARM OF ANTIBODY GAR03; COMPND 20 CHAIN: A; COMPND 21 ENGINEERED: YES; COMPND 22 OTHER_DETAILS: HEAVY CHAIN OF FAB ARM OF ANTIBODY GAR03; COMPND 23 MOL_ID: 5; COMPND 24 MOLECULE: LIGHT CHAIN OF FAB ARM OF ANTIBODY GAR03; COMPND 25 CHAIN: B; COMPND 26 ENGINEERED: YES; COMPND 27 OTHER_DETAILS: LIGHT CHAIN OF FAB ARM OF ANTIBODY GAR03 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: EXPICHO; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: EXPICHO; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 24 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 26 EXPRESSION_SYSTEM_CELL_LINE: EXPICHO; SOURCE 27 MOL_ID: 4; SOURCE 28 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 29 ORGANISM_COMMON: HUMAN; SOURCE 30 ORGANISM_TAXID: 9606; SOURCE 31 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 32 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 33 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 34 EXPRESSION_SYSTEM_CELL_LINE: EXPICHO; SOURCE 35 MOL_ID: 5; SOURCE 36 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 37 ORGANISM_COMMON: HUMAN; SOURCE 38 ORGANISM_TAXID: 9606; SOURCE 39 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 40 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 41 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 42 EXPRESSION_SYSTEM_CELL_LINE: EXPICHO KEYWDS ANTI-COV-2, ANTIBODIES, CONVALESCENT PATIENTS, RECEPTOR BINDING KEYWDS 2 DOMAIN., ANTIVIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.B.LANGLEY,D.CHRIST REVDAT 4 09-OCT-24 8DXU 1 REMARK REVDAT 3 03-APR-24 8DXU 1 REMARK REVDAT 2 22-FEB-23 8DXU 1 JRNL REVDAT 1 18-JAN-23 8DXU 0 JRNL AUTH R.ROUET,J.Y.HENRY,M.D.JOHANSEN,M.SOBTI,H.BALACHANDRAN, JRNL AUTH 2 D.B.LANGLEY,G.J.WALKER,H.LENTHALL,J.JACKSON,S.UBIPARIPOVIC, JRNL AUTH 3 O.MAZIGI,P.SCHOFIELD,D.L.BURNETT,S.H.J.BROWN,M.MARTINELLO, JRNL AUTH 4 B.HUDSON,N.GILROY,J.J.POST,A.KELLEHER,H.M.JACK,C.C.GOODNOW, JRNL AUTH 5 S.G.TURVILLE,W.D.RAWLINSON,R.A.BULL,A.G.STEWART,P.M.HANSBRO, JRNL AUTH 6 D.CHRIST JRNL TITL BROADLY NEUTRALIZING SARS-COV-2 ANTIBODIES THROUGH JRNL TITL 2 EPITOPE-BASED SELECTION FROM CONVALESCENT PATIENTS. JRNL REF NAT COMMUN V. 14 687 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36755042 JRNL DOI 10.1038/S41467-023-36295-5 REMARK 2 REMARK 2 RESOLUTION. 2.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1-2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.55 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 31114 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.730 REMARK 3 FREE R VALUE TEST SET COUNT : 1472 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.5470 - 6.0617 1.00 2898 142 0.2188 0.2552 REMARK 3 2 6.0617 - 4.8131 1.00 2772 137 0.1842 0.2307 REMARK 3 3 4.8131 - 4.2051 1.00 2717 141 0.1658 0.2160 REMARK 3 4 4.2051 - 3.8209 1.00 2702 151 0.1992 0.2545 REMARK 3 5 3.8209 - 3.5471 1.00 2693 133 0.2220 0.2452 REMARK 3 6 3.5471 - 3.3381 1.00 2711 110 0.2405 0.2902 REMARK 3 7 3.3381 - 3.1709 1.00 2661 148 0.2782 0.3314 REMARK 3 8 3.1709 - 3.0329 1.00 2664 142 0.2894 0.3239 REMARK 3 9 3.0329 - 2.9162 1.00 2664 109 0.2972 0.3844 REMARK 3 10 2.9162 - 2.8156 1.00 2666 136 0.3088 0.3949 REMARK 3 11 2.8156 - 2.7280 0.94 2494 123 0.3406 0.4181 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.410 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.530 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 59.81 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 64.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 8093 REMARK 3 ANGLE : 0.706 11071 REMARK 3 CHIRALITY : 0.046 1250 REMARK 3 PLANARITY : 0.005 1430 REMARK 3 DIHEDRAL : 8.123 5057 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -9.5853 11.3813 -58.3439 REMARK 3 T TENSOR REMARK 3 T11: 0.3383 T22: 0.3051 REMARK 3 T33: 0.3880 T12: -0.0150 REMARK 3 T13: 0.0322 T23: -0.0210 REMARK 3 L TENSOR REMARK 3 L11: 0.2762 L22: 0.3193 REMARK 3 L33: 0.2604 L12: 0.0138 REMARK 3 L13: -0.1882 L23: -0.2217 REMARK 3 S TENSOR REMARK 3 S11: -0.0286 S12: 0.0393 S13: 0.0603 REMARK 3 S21: -0.0682 S22: 0.0646 S23: 0.0133 REMARK 3 S31: 0.0782 S32: -0.0861 S33: -0.0150 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DXU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000267529. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31192 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.728 REMARK 200 RESOLUTION RANGE LOW (A) : 49.480 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 11.90 REMARK 200 R MERGE (I) : 0.15600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.8 REMARK 200 DATA REDUNDANCY IN SHELL : 10.10 REMARK 200 R MERGE FOR SHELL (I) : 1.38400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: GENERIC FAB AND SARS-COV-2 RBD REMARK 200 REMARK 200 REMARK: THIN PLATES REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TWO UL OF PROTEIN SOLUTION (~5 MG/ML REMARK 280 OF 1:1:1 COMPLEX IN 25 MM TRIS (PH 8.0), 200 MM NACL) WAS REMARK 280 COMBINED WITH AN EQUAL VOLUME OF WELL SOLUTION (100 MM MMT REMARK 280 BUFFER SYSTEM (MOLECULAR DIMENSIONS) (PH 6.0), 19% (W/V) REMARK 280 PEG6000., VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.61750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 100.91050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.04250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 100.91050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.61750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 51.04250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: R, H, L, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS R 519 REMARK 465 ALA R 520 REMARK 465 PRO R 521 REMARK 465 GLY R 529 REMARK 465 SER R 530 REMARK 465 HIS R 531 REMARK 465 HIS R 532 REMARK 465 HIS R 533 REMARK 465 HIS R 534 REMARK 465 HIS R 535 REMARK 465 HIS R 536 REMARK 465 CYS H 220 REMARK 465 GLY H 221 REMARK 465 SER H 222 REMARK 465 HIS H 223 REMARK 465 HIS H 224 REMARK 465 HIS H 225 REMARK 465 HIS H 226 REMARK 465 HIS H 227 REMARK 465 HIS H 228 REMARK 465 GLU L 213 REMARK 465 CYS L 214 REMARK 465 SER L 215 REMARK 465 SER A 222 REMARK 465 CYS A 223 REMARK 465 GLY A 224 REMARK 465 SER A 225 REMARK 465 HIS A 226 REMARK 465 HIS A 227 REMARK 465 HIS A 228 REMARK 465 HIS A 229 REMARK 465 HIS A 230 REMARK 465 HIS A 231 REMARK 465 GLU B 214 REMARK 465 CYS B 215 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR R 333 OG1 CG2 REMARK 470 ASN R 334 CG OD1 ND2 REMARK 470 TYR R 369 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS R 386 CG CD CE NZ REMARK 470 LYS R 444 CG CD CE NZ REMARK 470 LEU R 517 CG CD1 CD2 REMARK 470 LEU R 518 CG CD1 CD2 REMARK 470 ARG H 87 CG CD NE CZ NH1 NH2 REMARK 470 LYS H 133 CG CD CE NZ REMARK 470 LYS H 210 CG CD CE NZ REMARK 470 LYS H 214 CG CD CE NZ REMARK 470 GLU H 216 CG CD OE1 OE2 REMARK 470 LYS H 218 CG CD CE NZ REMARK 470 SER H 219 OG REMARK 470 ASN L 1 CG OD1 ND2 REMARK 470 LYS L 42 CG CD CE NZ REMARK 470 GLU L 123 CG CD OE1 OE2 REMARK 470 LEU L 125 CG CD1 CD2 REMARK 470 LYS L 126 CG CD CE NZ REMARK 470 LYS L 145 CG CD CE NZ REMARK 470 GLN L 147 CG CD OE1 NE2 REMARK 470 LYS L 169 CG CD CE NZ REMARK 470 LYS L 188 CG CD CE NZ REMARK 470 LYS L 190 CG CD CE NZ REMARK 470 GLN A 1 CG CD OE1 NE2 REMARK 470 GLN A 62 CG CD OE1 NE2 REMARK 470 ARG A 87 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 GLN A 199 CG CD OE1 NE2 REMARK 470 LYS A 208 CG CD CE NZ REMARK 470 LYS A 213 CG CD CE NZ REMARK 470 LYS A 217 CG CD CE NZ REMARK 470 LYS A 221 CG CD CE NZ REMARK 470 ARG B 21 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 41 CG CD OE1 NE2 REMARK 470 GLU B 59 CG CD OE1 OE2 REMARK 470 ARG B 76 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 82 CG CD OE1 OE2 REMARK 470 LEU B 110 CG CD1 CD2 REMARK 470 GLN B 112 CG CD OE1 NE2 REMARK 470 LYS B 114 CG CD CE NZ REMARK 470 ASN B 132 CG OD1 ND2 REMARK 470 LYS B 133 CG CD CE NZ REMARK 470 LYS B 160 CG CD CE NZ REMARK 470 LYS B 170 CG CD CE NZ REMARK 470 LYS B 175 CG CD CE NZ REMARK 470 TYR B 176 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN B 198 CG CD OE1 NE2 REMARK 470 GLU B 202 CG CD OE1 OE2 REMARK 470 THR B 213 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR L 186 OH TYR L 192 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA R 352 56.52 -110.44 REMARK 500 ASN R 360 66.56 60.26 REMARK 500 ASN R 370 4.78 -69.86 REMARK 500 ALA R 372 79.19 -100.25 REMARK 500 ASN R 422 -60.86 -126.92 REMARK 500 ASP R 428 33.86 -95.23 REMARK 500 VAL H 48 -60.59 -106.87 REMARK 500 SER H 56 -131.79 60.41 REMARK 500 VAL H 64 -15.47 -145.57 REMARK 500 ALA H 102 35.09 -95.18 REMARK 500 SER H 116 158.25 179.62 REMARK 500 THR H 135 -5.40 -55.90 REMARK 500 SER H 136 134.47 61.30 REMARK 500 ASP H 148 75.24 55.53 REMARK 500 GLN L 3 125.28 73.96 REMARK 500 SER L 30 -130.34 56.63 REMARK 500 TYR L 32 77.94 -102.35 REMARK 500 ALA L 51 -30.86 71.59 REMARK 500 SER L 52 -0.85 -145.26 REMARK 500 ARG L 108 168.67 63.26 REMARK 500 ASN L 152 24.67 48.45 REMARK 500 ASN L 158 19.77 -142.33 REMARK 500 LYS L 169 -73.82 -92.25 REMARK 500 LYS L 190 -66.91 -101.30 REMARK 500 ARG L 211 93.88 -47.13 REMARK 500 GLN A 6 -155.59 -91.07 REMARK 500 SER A 25 -84.84 -113.73 REMARK 500 ASN A 105 78.71 67.81 REMARK 500 ASP A 151 85.74 51.04 REMARK 500 SER A 195 31.29 -145.16 REMARK 500 GLU B 24 148.98 -171.21 REMARK 500 ASP B 50 -48.77 70.49 REMARK 500 PRO B 113 -173.62 -62.20 REMARK 500 LYS B 114 51.41 -116.71 REMARK 500 ASP B 142 35.52 38.66 REMARK 500 PRO B 145 -89.06 -62.29 REMARK 500 ALA B 147 -156.44 -103.28 REMARK 500 VAL B 148 144.17 144.52 REMARK 500 SER B 156 -21.62 68.02 REMARK 500 LYS B 160 -21.05 68.35 REMARK 500 ASN B 174 3.64 100.88 REMARK 500 GLU B 202 -84.97 52.86 REMARK 500 PRO B 212 -177.86 -68.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU H 152 PRO H 153 123.97 REMARK 500 REMARK 500 REMARK: NULL DBREF 8DXU R 333 528 UNP P0DTC2 SPIKE_SARS2 333 528 DBREF 8DXU H 1 228 PDB 8DXU 8DXU 1 228 DBREF 8DXU L 1 215 PDB 8DXU 8DXU 1 215 DBREF 8DXU A 1 231 PDB 8DXU 8DXU 1 231 DBREF 8DXU B 1 215 PDB 8DXU 8DXU 1 215 SEQADV 8DXU GLY R 529 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXU SER R 530 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXU HIS R 531 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXU HIS R 532 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXU HIS R 533 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXU HIS R 534 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXU HIS R 535 UNP P0DTC2 EXPRESSION TAG SEQADV 8DXU HIS R 536 UNP P0DTC2 EXPRESSION TAG SEQRES 1 R 204 THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR SEQRES 2 R 204 ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SEQRES 3 R 204 SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER SEQRES 4 R 204 ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO SEQRES 5 R 204 THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA SEQRES 6 R 204 ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE SEQRES 7 R 204 ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR SEQRES 8 R 204 LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP SEQRES 9 R 204 ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR SEQRES 10 R 204 ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS SEQRES 11 R 204 PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA SEQRES 12 R 204 GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS SEQRES 13 R 204 TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN SEQRES 14 R 204 GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER SEQRES 15 R 204 PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO SEQRES 16 R 204 LYS GLY SER HIS HIS HIS HIS HIS HIS SEQRES 1 H 228 GLN VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN SEQRES 2 H 228 PRO GLY ARG SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 228 PHE THR PHE SER SER TYR GLY MET HIS TRP VAL ARG GLN SEQRES 4 H 228 ALA PRO GLY LYS GLY LEU GLU TRP VAL ALA VAL ILE TRP SEQRES 5 H 228 TYR ASP GLY SER ASP LYS TYR TYR ALA ASP SER VAL LYS SEQRES 6 H 228 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 H 228 LEU TYR LEU GLN ILE ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 H 228 ALA MET TYR TYR CYS ALA ARG GLU ALA THR ALA GLY PHE SEQRES 9 H 228 ASP TYR TRP GLY GLN GLY ASN LEU VAL THR VAL SER SER SEQRES 10 H 228 ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SEQRES 11 H 228 SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY SEQRES 12 H 228 CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SEQRES 13 H 228 SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR SEQRES 14 H 228 PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SEQRES 15 H 228 SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR SEQRES 16 H 228 GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN SEQRES 17 H 228 THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS GLY SEQRES 18 H 228 SER HIS HIS HIS HIS HIS HIS SEQRES 1 L 215 ASN ILE GLN MET THR GLN SER PRO SER ALA MET SER ALA SEQRES 2 L 215 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA ARG SEQRES 3 L 215 GLN ASP ILE SER SER TYR LEU ALA TRP PHE GLN GLN LYS SEQRES 4 L 215 PRO GLY LYS VAL PRO LYS HIS LEU ILE TYR ALA ALA SER SEQRES 5 L 215 THR LEU LEU SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 L 215 GLY SER GLY THR GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 L 215 GLN PRO GLU ASP PHE ALA THR TYR TYR CYS LEU GLN HIS SEQRES 8 L 215 ASN SER TYR PRO TYR THR PHE GLY GLN GLY THR LYS LEU SEQRES 9 L 215 GLU ILE ASN ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 L 215 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 L 215 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 L 215 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 L 215 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 L 215 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 L 215 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 L 215 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 L 215 PHE ASN ARG GLY GLU CYS SER SEQRES 1 A 231 GLN VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 A 231 PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 A 231 TYR THR PHE SER SER TYR ASP ILE ASN TRP VAL ARG GLN SEQRES 4 A 231 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY TRP MET SER SEQRES 5 A 231 PRO ASN SER GLY ASN THR GLY TYR ALA GLN LYS PHE GLN SEQRES 6 A 231 GLY ARG VAL THR MET THR ARG SER THR SER MET SER THR SEQRES 7 A 231 ALA TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR SEQRES 8 A 231 ALA VAL TYR PHE CYS ALA ARG MET SER SER SER LEU THR SEQRES 9 A 231 ASN TYR LEU ASP TYR TRP GLY GLN GLY THR LEU VAL THR SEQRES 10 A 231 VAL SER SER ALA SER THR LYS GLY PRO SER VAL PHE PRO SEQRES 11 A 231 LEU ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA SEQRES 12 A 231 ALA LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO SEQRES 13 A 231 VAL THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY SEQRES 14 A 231 VAL HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU SEQRES 15 A 231 TYR SER LEU SER SER VAL VAL THR VAL PRO SER SER SER SEQRES 16 A 231 LEU GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS SEQRES 17 A 231 PRO SER ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SEQRES 18 A 231 SER CYS GLY SER HIS HIS HIS HIS HIS HIS SEQRES 1 B 215 SER TYR VAL LEU THR GLN PRO PRO SER VAL ALA VAL ALA SEQRES 2 B 215 PRO GLY GLN THR ALA ARG ILE ARG CYS GLY GLU ASN ASP SEQRES 3 B 215 ILE GLY SER LYS ASN VAL HIS TRP TYR GLN GLN LYS SER SEQRES 4 B 215 GLY GLN ALA PRO VAL LEU VAL VAL TYR ASP ASP SER ASP SEQRES 5 B 215 ARG PRO SER GLY ILE PRO GLU ARG PHE SER GLY SER ASN SEQRES 6 B 215 SER GLY ASN THR ALA THR LEU THR ILE SER ARG VAL GLU SEQRES 7 B 215 ALA GLY ASP GLU ALA ASP TYR TYR CYS GLN VAL TRP ASP SEQRES 8 B 215 SER THR GLY ASP HIS PRO ASP VAL VAL PHE GLY GLY GLY SEQRES 9 B 215 THR LYS LEU THR VAL LEU GLY GLN PRO LYS ALA ALA PRO SEQRES 10 B 215 SER VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 B 215 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 B 215 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SEQRES 13 B 215 SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER SEQRES 14 B 215 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 B 215 SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SEQRES 16 B 215 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 B 215 THR VAL ALA PRO THR GLU CYS HET NAG R 601 14 HET CL A 301 1 HET CL A 302 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 6 NAG C8 H15 N O6 FORMUL 7 CL 2(CL 1-) FORMUL 9 HOH *43(H2 O) HELIX 1 AA1 PRO R 337 ASN R 343 1 7 HELIX 2 AA2 TYR R 365 ASN R 370 1 6 HELIX 3 AA3 PRO R 384 ASP R 389 5 6 HELIX 4 AA4 ASP R 405 ILE R 410 5 6 HELIX 5 AA5 GLY R 416 ASN R 422 1 7 HELIX 6 AA6 SER R 438 SER R 443 1 6 HELIX 7 AA7 GLY R 502 TYR R 505 5 4 HELIX 8 AA8 THR H 28 TYR H 32 5 5 HELIX 9 AA9 ARG H 87 THR H 91 5 5 HELIX 10 AB1 SER H 160 ALA H 162 5 3 HELIX 11 AB2 SER H 191 GLY H 194 5 4 HELIX 12 AB3 LYS H 205 ASN H 208 5 4 HELIX 13 AB4 GLN L 79 PHE L 83 5 5 HELIX 14 AB5 SER L 121 GLY L 128 1 8 HELIX 15 AB6 LYS L 183 GLU L 187 1 5 HELIX 16 AB7 THR A 28 TYR A 32 5 5 HELIX 17 AB8 GLN A 62 GLN A 65 5 4 HELIX 18 AB9 ARG A 87 THR A 91 5 5 HELIX 19 AC1 SER A 134 THR A 138 5 5 HELIX 20 AC2 LYS A 208 ASN A 211 5 4 HELIX 21 AC3 ASP B 26 LYS B 30 5 5 HELIX 22 AC4 SER B 125 ALA B 131 1 7 HELIX 23 AC5 THR B 185 HIS B 192 1 8 SHEET 1 AA1 4 ASN R 354 ILE R 358 0 SHEET 2 AA1 4 CYS R 391 ARG R 403 -1 O VAL R 395 N ILE R 358 SHEET 3 AA1 4 THR R 523 CYS R 525 -1 O VAL R 524 N PHE R 392 SHEET 4 AA1 4 CYS R 361 VAL R 362 1 N CYS R 361 O CYS R 525 SHEET 1 AA2 5 ASN R 354 ILE R 358 0 SHEET 2 AA2 5 CYS R 391 ARG R 403 -1 O VAL R 395 N ILE R 358 SHEET 3 AA2 5 PRO R 507 LEU R 518 -1 O VAL R 512 N ASP R 398 SHEET 4 AA2 5 GLY R 431 ASN R 437 -1 N ILE R 434 O VAL R 511 SHEET 5 AA2 5 THR R 376 TYR R 380 -1 N TYR R 380 O GLY R 431 SHEET 1 AA3 2 LEU R 452 ARG R 454 0 SHEET 2 AA3 2 LEU R 492 SER R 494 -1 O GLN R 493 N TYR R 453 SHEET 1 AA4 2 TYR R 473 GLN R 474 0 SHEET 2 AA4 2 CYS R 488 TYR R 489 -1 O TYR R 489 N TYR R 473 SHEET 1 AA5 4 GLN H 3 SER H 7 0 SHEET 2 AA5 4 LEU H 18 SER H 25 -1 O ALA H 23 N VAL H 5 SHEET 3 AA5 4 THR H 78 ILE H 83 -1 O LEU H 81 N LEU H 20 SHEET 4 AA5 4 PHE H 68 ASP H 73 -1 N SER H 71 O TYR H 80 SHEET 1 AA6 6 GLY H 10 VAL H 12 0 SHEET 2 AA6 6 ASN H 111 VAL H 115 1 O THR H 114 N GLY H 10 SHEET 3 AA6 6 ALA H 92 ALA H 100 -1 N TYR H 94 O ASN H 111 SHEET 4 AA6 6 GLY H 33 GLN H 39 -1 N VAL H 37 O TYR H 95 SHEET 5 AA6 6 LEU H 45 TRP H 52 -1 O VAL H 48 N TRP H 36 SHEET 6 AA6 6 GLY H 55 TYR H 60 -1 O ASP H 57 N TRP H 52 SHEET 1 AA7 4 GLY H 10 VAL H 12 0 SHEET 2 AA7 4 ASN H 111 VAL H 115 1 O THR H 114 N GLY H 10 SHEET 3 AA7 4 ALA H 92 ALA H 100 -1 N TYR H 94 O ASN H 111 SHEET 4 AA7 4 GLY H 103 TRP H 107 -1 O GLY H 103 N ALA H 100 SHEET 1 AA8 4 SER H 124 LEU H 128 0 SHEET 2 AA8 4 THR H 139 TYR H 149 -1 O GLY H 143 N LEU H 128 SHEET 3 AA8 4 TYR H 180 PRO H 189 -1 O TYR H 180 N TYR H 149 SHEET 4 AA8 4 VAL H 167 THR H 169 -1 N HIS H 168 O VAL H 185 SHEET 1 AA9 4 SER H 124 LEU H 128 0 SHEET 2 AA9 4 THR H 139 TYR H 149 -1 O GLY H 143 N LEU H 128 SHEET 3 AA9 4 TYR H 180 PRO H 189 -1 O TYR H 180 N TYR H 149 SHEET 4 AA9 4 VAL H 173 LEU H 174 -1 N VAL H 173 O SER H 181 SHEET 1 AB1 3 THR H 155 TRP H 158 0 SHEET 2 AB1 3 ILE H 199 HIS H 204 -1 O ASN H 201 N SER H 157 SHEET 3 AB1 3 THR H 209 LYS H 214 -1 O VAL H 211 N VAL H 202 SHEET 1 AB2 4 MET L 4 SER L 7 0 SHEET 2 AB2 4 VAL L 19 ALA L 25 -1 O THR L 22 N SER L 7 SHEET 3 AB2 4 GLU L 70 ILE L 75 -1 O ILE L 75 N VAL L 19 SHEET 4 AB2 4 PHE L 62 SER L 67 -1 N SER L 63 O THR L 74 SHEET 1 AB3 6 ALA L 10 ALA L 13 0 SHEET 2 AB3 6 THR L 102 ILE L 106 1 O GLU L 105 N MET L 11 SHEET 3 AB3 6 THR L 85 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 AB3 6 LEU L 33 GLN L 38 -1 N PHE L 36 O TYR L 87 SHEET 5 AB3 6 LYS L 45 TYR L 49 -1 O LYS L 45 N GLN L 37 SHEET 6 AB3 6 THR L 53 LEU L 54 -1 O THR L 53 N TYR L 49 SHEET 1 AB4 4 ALA L 10 ALA L 13 0 SHEET 2 AB4 4 THR L 102 ILE L 106 1 O GLU L 105 N MET L 11 SHEET 3 AB4 4 THR L 85 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 AB4 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 AB5 4 SER L 114 PHE L 118 0 SHEET 2 AB5 4 THR L 129 PHE L 139 -1 O LEU L 135 N PHE L 116 SHEET 3 AB5 4 TYR L 173 SER L 182 -1 O LEU L 179 N VAL L 132 SHEET 4 AB5 4 SER L 159 VAL L 163 -1 N SER L 162 O SER L 176 SHEET 1 AB6 4 ALA L 153 LEU L 154 0 SHEET 2 AB6 4 ALA L 144 VAL L 150 -1 N VAL L 150 O ALA L 153 SHEET 3 AB6 4 VAL L 191 HIS L 198 -1 O GLU L 195 N GLN L 147 SHEET 4 AB6 4 VAL L 205 ASN L 210 -1 O PHE L 209 N TYR L 192 SHEET 1 AB7 4 LEU A 4 GLN A 6 0 SHEET 2 AB7 4 VAL A 18 ALA A 24 -1 O LYS A 23 N VAL A 5 SHEET 3 AB7 4 THR A 78 LEU A 83 -1 O ALA A 79 N CYS A 22 SHEET 4 AB7 4 VAL A 68 SER A 73 -1 N THR A 71 O TYR A 80 SHEET 1 AB8 6 GLU A 10 LYS A 12 0 SHEET 2 AB8 6 THR A 114 VAL A 118 1 O THR A 117 N LYS A 12 SHEET 3 AB8 6 ALA A 92 MET A 99 -1 N TYR A 94 O THR A 114 SHEET 4 AB8 6 ILE A 34 GLN A 39 -1 N VAL A 37 O PHE A 95 SHEET 5 AB8 6 LEU A 45 MET A 51 -1 O GLU A 46 N ARG A 38 SHEET 6 AB8 6 THR A 58 TYR A 60 -1 O GLY A 59 N TRP A 50 SHEET 1 AB9 4 GLU A 10 LYS A 12 0 SHEET 2 AB9 4 THR A 114 VAL A 118 1 O THR A 117 N LYS A 12 SHEET 3 AB9 4 ALA A 92 MET A 99 -1 N TYR A 94 O THR A 114 SHEET 4 AB9 4 LEU A 107 TRP A 110 -1 O TYR A 109 N ARG A 98 SHEET 1 AC1 4 SER A 127 LEU A 131 0 SHEET 2 AC1 4 THR A 142 TYR A 152 -1 O LEU A 148 N PHE A 129 SHEET 3 AC1 4 TYR A 183 PRO A 192 -1 O TYR A 183 N TYR A 152 SHEET 4 AC1 4 VAL A 170 THR A 172 -1 N HIS A 171 O VAL A 188 SHEET 1 AC2 4 SER A 127 LEU A 131 0 SHEET 2 AC2 4 THR A 142 TYR A 152 -1 O LEU A 148 N PHE A 129 SHEET 3 AC2 4 TYR A 183 PRO A 192 -1 O TYR A 183 N TYR A 152 SHEET 4 AC2 4 VAL A 176 LEU A 177 -1 N VAL A 176 O SER A 184 SHEET 1 AC3 3 THR A 158 TRP A 161 0 SHEET 2 AC3 3 ILE A 202 HIS A 207 -1 O ASN A 204 N SER A 160 SHEET 3 AC3 3 THR A 212 LYS A 217 -1 O VAL A 214 N VAL A 205 SHEET 1 AC4 5 SER B 9 ALA B 11 0 SHEET 2 AC4 5 THR B 105 THR B 108 1 O LYS B 106 N VAL B 10 SHEET 3 AC4 5 ASP B 84 ASP B 91 -1 N TYR B 85 O THR B 105 SHEET 4 AC4 5 HIS B 33 GLN B 37 -1 N GLN B 37 O ASP B 84 SHEET 5 AC4 5 VAL B 44 VAL B 47 -1 O VAL B 44 N GLN B 36 SHEET 1 AC5 4 SER B 9 ALA B 11 0 SHEET 2 AC5 4 THR B 105 THR B 108 1 O LYS B 106 N VAL B 10 SHEET 3 AC5 4 ASP B 84 ASP B 91 -1 N TYR B 85 O THR B 105 SHEET 4 AC5 4 ASP B 98 PHE B 101 -1 O ASP B 98 N ASP B 91 SHEET 1 AC6 3 ALA B 18 GLY B 23 0 SHEET 2 AC6 3 THR B 69 ILE B 74 -1 O ALA B 70 N CYS B 22 SHEET 3 AC6 3 PHE B 61 ASN B 65 -1 N SER B 62 O THR B 73 SHEET 1 AC7 4 SER B 118 PHE B 122 0 SHEET 2 AC7 4 ALA B 134 PHE B 143 -1 O LEU B 139 N THR B 120 SHEET 3 AC7 4 TYR B 176 LEU B 184 -1 O TYR B 176 N PHE B 143 SHEET 4 AC7 4 VAL B 163 THR B 165 -1 N GLU B 164 O TYR B 181 SHEET 1 AC8 4 SER B 118 PHE B 122 0 SHEET 2 AC8 4 ALA B 134 PHE B 143 -1 O LEU B 139 N THR B 120 SHEET 3 AC8 4 TYR B 176 LEU B 184 -1 O TYR B 176 N PHE B 143 SHEET 4 AC8 4 SER B 169 LYS B 170 -1 N SER B 169 O ALA B 177 SHEET 1 AC9 4 SER B 157 PRO B 158 0 SHEET 2 AC9 4 THR B 149 ALA B 154 -1 N ALA B 154 O SER B 157 SHEET 3 AC9 4 TYR B 195 HIS B 201 -1 O GLN B 198 N ALA B 151 SHEET 4 AC9 4 SER B 204 VAL B 210 -1 O SER B 204 N HIS B 201 SSBOND 1 CYS R 336 CYS R 361 1555 1555 2.03 SSBOND 2 CYS R 379 CYS R 432 1555 1555 2.04 SSBOND 3 CYS R 391 CYS R 525 1555 1555 2.03 SSBOND 4 CYS R 480 CYS R 488 1555 1555 2.04 SSBOND 5 CYS H 22 CYS H 96 1555 1555 2.04 SSBOND 6 CYS H 144 CYS H 200 1555 1555 2.03 SSBOND 7 CYS L 23 CYS L 88 1555 1555 2.04 SSBOND 8 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 9 CYS A 22 CYS A 96 1555 1555 2.03 SSBOND 10 CYS A 147 CYS A 203 1555 1555 2.03 SSBOND 11 CYS B 22 CYS B 87 1555 1555 2.04 SSBOND 12 CYS B 138 CYS B 197 1555 1555 2.03 LINK ND2 ASN R 343 C1 NAG R 601 1555 1555 1.39 CISPEP 1 PHE H 150 PRO H 151 0 -4.77 CISPEP 2 SER L 7 PRO L 8 0 0.28 CISPEP 3 TYR L 94 PRO L 95 0 -1.62 CISPEP 4 TYR L 140 PRO L 141 0 -2.98 CISPEP 5 PHE A 153 PRO A 154 0 -5.16 CISPEP 6 GLU A 155 PRO A 156 0 6.91 CISPEP 7 TYR B 144 PRO B 145 0 7.05 CRYST1 55.235 102.085 201.821 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018104 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009796 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004955 0.00000